Carl Pearson, MSES, PhD
Clinic Director for MMED '23, '24Faculty Member, SEAMS, MMED, and DAIDD
Research Fellow
London School of Hygiene & Tropical Medicine
London, United Kingdom
PhD in Physics, The George Washington University (2012)
MSES in Mechincal Engineering, The Naval Post Graduate School (2006)
BS in Mathematics & Physics, Duke University (2003)
About: Carl is a Research Fellow at the London School of Hygiene & Tropical Medicine, focusing on Ebola. He is also affiliated with SACEMA. He was a Faculty Observer at MMED 2015 and joined the Workshop Faculty in 2016.
Selected publications:
Pearson, Clifford, Pulliam, Eggo. (2021) Pre-vaccination testing could expand coverage of two-dose COVID vaccines. Wellcome Open Research
Pearson, van Schalkwyk, Foss, O’Reilly, SACEMA Modelling and Analysis Response Team, CMMID COVID-19 Working Group, Pulliam. (2020) Projected early spread of COVID-19 in Africa through 1 June 2020. Eurosurveillance
Pearson, Abbas, Clifford, Flasche, Hladish. (2019) Serostatus testing and dengue vaccine cost–benefit thresholds. Journal of the Royal Society Interface
Flasche, Jit, Rodríguez-Barraquer, Coudeville, Recker, Koelle, Milne, Hladish, Perkins, Cummings, Dorigatti, Laydon, España, Kelso, Longini, Lourenco, Pearson, Reiner, Mier-y-Terán-Romero, Vannice, Ferguson. (2017) The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia) - a model comparison study. PLoS Medicine
Hladish, Pearson, Chao, Rojas, Recchia, Gómez-Dantés, M Halloran, Pulliam, Longini. (2016) Projected impact of dengue vaccination in Yucatán, Mexico. PLOS Neglected Tropical Diseases